Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000040

Chief Technology Officer sold 4,875 shares at an average $16.78 ($81,790)

From the SEC's structured data for this filing

Trades in this filing

Kurtoglu Metin · Chief Technology Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-03 Sale : show line 1 in the form −2,417 $16.72 $40,417 64,716 D
2025-01-06 Sale : show line 2 in the form −2,458 $16.83 $41,374 62,258 D
Open-market sales · 4,875 sh · avg $16.78 · $81,790
Loading xslF345X05/wk-form4_1736298335.xml…